Balls, Jason, PA-C, MMAS

placeholder image

visualizations

Publications in VIVO

Co-author Network

Balls, Jason, PA-C, MMAS
Close

research areas

Most Recent Publications

2021

Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections. TRANSPLANTATION AND CELLULAR THERAPY. 27.
Full Text via DOI: 10.1016/j.jtct.2021.02.025 PMID: 33849818
2020

Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia. LEUKEMIA & LYMPHOMA. 61:2839-2849.
Full Text via DOI: 10.1080/10428194.2020.1789630 PMID: 32650686
2020

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S126-S127.
2018

Addition of Cladribine: Improving Standard of Care in Newly Diagnosed Acute Myeloid Leukemia. BLOOD.
Full Text via DOI: 10.1182/blood-2018-99-120285
2018

Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and is Associated with Decrease Risks of Severe Acute and Chronic Gvhd. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S327-S327.
2017

Transverse Myelitis As a Manifestation of Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S310-S310.
2014

Guilain-Barre' Syndrome (GBS) Post Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia (CLL). BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S281-S281.
2014

Improving Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Scores in Bone Marrow Transplant Inpatient Setting. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S126-S126.
2014

Low Dose Thymoglobulin Result in Improved Outcomes after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome Conditioned with Intravenous Busulfan and Fludarabine. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S233-S234.

Full Name

Jason Balls, PA-C